Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The study of hypertrophic cardiomyopathy has been at the vanguard of molecular genetic investigation into inherited diseases of the cardiovascular system for the greater part of the last decade. These studies have shown it to be a disease of sarcomeric contractile proteins and have highlighted its genetic heterogeneity. There are now seven known genetic loci and six disease genes associated with the condition. The biology of the mutant polypeptides has been studied in vitro, and animal models are being developed. Increased understanding gained from these studies has clarified features of the condition at the clinical level and has had an impact on management of patients. It is hoped that this work will lead to the development of novel therapies for both hypertrophic cardiomyopathy and acquired forms of left ventricular hypertrophy.


Journal article


Curr Opin Cardiol

Publication Date





295 - 302


Animals, Cardiomyopathy, Hypertrophic, Chromosome Mapping, DNA Mutational Analysis, Genetic Markers, Genotype, Humans, Hypertrophy, Left Ventricular, Mice, Molecular Biology, Myosins, Pedigree, Phenotype